$SNEX

Smith Philip Andrew sold $962K of SNEX

Smith Philip Andrew (Chief Executive Officer) sold 8,535 shares of StoneX Group Inc. (SNEX) at $112.72 ($0.96M total) on 2026-05-22 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Smith Philip Andrew
Published May 26, 2026, 8:11 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI May 26, 2026, 8:19 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$SNEX
Neutral
high confidence
Mentioned
$SNEX
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$SNEXNeutralLow
01

Why it matters

This disclosure may slightly affect sentiment, but it does not introduce new information about StoneX’s business, earnings, deals, or risk exposures.

02

Market read

Traders may monitor for unusual insider activity, but 10b5-1 sales are generally treated as lower-signal than unscheduled selling.

03

What to watch

The article provides only the sale size and post-transaction holdings; without context on prior sales cadence or total insider ownership, directional inference is weak.

Relevance 6/10Timing: Disclosure filed 2026-05-26 for a sale dated 2026-05-22; potential minor market reaction around filing time.

Background

The article summarizes an SEC Form 4 insider transaction for StoneX Group Inc., reporting an open-market sale by the CEO under a pre-arranged 10b5-1 plan.

Company-level read

Ticker impact

$SNEXNeutralHigh confidence
Context

StoneX Group CEO Philip Andrew Smith sold 8,535 shares in an open-market transaction under a pre-arranged 10b5-1 plan.

Expected impact

Low near-term impact; any reaction is likely limited to intraday/short-term positioning rather than a trend change.

Evidence & confidence

The filing is an officer sale under a pre-arranged 10b5-1 plan, with no accompanying operational or financial catalyst described in the article.

Market effects

Minimal; this is company-specific insider transaction disclosure with no sector-wide catalyst mentioned.

Minimal; no geographic or cross-border linkage provided.

Minimal; no international transaction or global regulatory development referenced.

Counterpoint

Because the sale is under a 10b5-1 plan, it may reflect routine liquidity planning rather than bearish expectations.

Key entities

  • StoneX Group Inc.

    Subject of the Form 4 insider transaction disclosure (SNEX).

  • Philip Andrew Smith

    CEO and director who sold shares under a pre-arranged 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$WGOMedAI 8/10

Winnebago stock rises as StoneX lowers price target on industry outlook

StoneX lowered its price target on Winnebago (WGO) to $36 from $40, maintaining a Buy rating. The stock trades at $26.83 with a 5.62% dividend yield. Winnebago issued fiscal 2027 guidance for sales of $2.65B-$2.80B and adjusted EPS of $1.65-$2.25, with midpoints above consensus. The company reduced 2026 RV shipment expectations and guided 2027 shipments to 265,000-295,000 units. The stock rose 10.5% on Monday following earnings and guidance.

$MXLMed

MaxLinear stock rating reiterated at Buy by StoneX ahead of results

StoneX reiterated a Buy rating on MaxLinear (MXL) with a $125 price target ahead of its October 22 earnings report. The firm expects Q3 revenue of $215M-$220M, matching consensus. MXL shares are down 20% in a week but up 320% year-to-date. S&P upgraded its outlook to positive, citing strong infrastructure revenue growth. Analysts highlight MXL's potential in the optical market.

$EQBKMed

StoneX lowers Equity Bancshares stock price target on NIM outlook

StoneX reduced its price target for Equity Bancshares (EQBK) to $58 from $59, citing net interest margin expectations. The firm raised its fiscal 2026 EPS forecast to $5.18 but lowered the 2027 estimate to $5.27. EQBK's stock trades at a P/E ratio of 10.58, and analysts expect net income growth. The company recently reported Q3 earnings beating estimates, with EPS of $1.40 vs. $1.29 expected, but revenue missed slightly.